Graham NM - Search Results

1

Potential factors affecting adherence with HIV therapy.

Mehta S, Moore RD, Graham NM. Mehta S, et al. Among authors: graham nm. AIDS. 1997 Nov 15;11(14):1665-70. doi: 10.1097/00002030-199714000-00002. AIDS. 1997. PMID: 9386800 Review. No abstract available.

2

Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.

Sterling TR, Moore RD, Graham NM, Astemborski J, Vlahov D, Chaisson RE. Sterling TR, et al. Among authors: graham nm. AIDS. 1998 Aug 20;12(12):1451-7. doi: 10.1097/00002030-199812000-00006. AIDS. 1998. PMID: 9727565

3

On 'Specific nutrient abnormalities in asymptomatic HIV-1 infection'.

Graham NM. Graham NM. AIDS. 1992 Dec;6(12):1552-3. doi: 10.1097/00002030-199212000-00027. AIDS. 1992. PMID: 1492944 No abstract available.

4

The role of immunologic and viral markers in predicting clinical outcome in HIV infection.

Graham NM. Graham NM. AIDS. 1996 Dec;10 Suppl 5:S21-5. doi: 10.1097/00002030-199612005-00004. AIDS. 1996. PMID: 9030392 Review.

5

Association between serum vitamin A and E levels and HIV-1 disease progression.

Tang AM, Graham NM, Semba RD, Saah AJ. Tang AM, et al. Among authors: graham nm. AIDS. 1997 Apr;11(5):613-20. doi: 10.1097/00002030-199705000-00009. AIDS. 1997. PMID: 9108943

6

The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.

Lyles CM, Margolick JB, Astemborski J, Graham NM, Anthony JC, Hoover DR, Vlahov D. Lyles CM, et al. Among authors: graham nm. AIDS. 1997 Aug;11(10):1255-62. doi: 10.1097/00002030-199710000-00009. AIDS. 1997. PMID: 9256944

7

Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 x 10(6)/l.

Hoover DR, Rinaldo C, He Y, Phair J, Fahey J, Graham NM. Hoover DR, et al. Among authors: graham nm. AIDS. 1995 Feb;9(2):145-52. AIDS. 1995. PMID: 7718184

8

The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users.

Manoff SB, Farzadegan H, Muñoz A, Astemborski JA, Vlahov D, Rizzo RT, Solomon L, Graham NM. Manoff SB, et al. Among authors: graham nm. J Infect Dis. 1996 Aug;174(2):299-308. doi: 10.1093/infdis/174.2.299. J Infect Dis. 1996. PMID: 8699059

9

Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.

Graham NM, Galai N, Nelson KE, Astemborski J, Bonds M, Rizzo RT, Sheeley L, Vlahov D. Graham NM, et al. Arch Intern Med. 1996 Apr 22;156(8):889-94. Arch Intern Med. 1996. PMID: 8774208 Clinical Trial.

10

Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.

Kimura M, Converse PJ, Astemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NM, Chaisson RE, Bishai WR. Kimura M, et al. Among authors: graham nm. J Infect Dis. 1999 May;179(5):1297-300. doi: 10.1086/314707. J Infect Dis. 1999. PMID: 10191241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters